Clearmind Medicine
CMND
3 hedge funds and large institutions have $276K invested in Clearmind Medicine in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
57% more capital invested
Capital invested by funds: $175K → $276K (+$101K)
0.17% more ownership
Funds ownership: 4.84% → 5.01% (+0.17%)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWG
Cornerstone Wealth Group
Huntersville,
North Carolina
|
+$23.2K |
| 2 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$19.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$27.3K |
CMND Hedge Fund Activity: Q2 2024 in Review
3 of the 6,939 institutional investors tracked by Wall St. Rank reported a position in Clearmind Medicine (CMND) for Q2 2024, worth a combined $276K — up 57% from $175K a quarter earlier.
Fund positioning in CMND was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Cornerstone Wealth Group, opening a new position worth an estimated $23.2K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $27.3K sold.
- 3 institutional investors held Clearmind Medicine (CMND) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $276K of Clearmind Medicine stock for Q2 2024, up 57% quarter-over-quarter.
- 1 fund opened new Clearmind Medicine positions in Q2 2024 and 1 closed out, a net change of 0 holders.
- The largest Clearmind Medicine buyer in Q2 2024 was Cornerstone Wealth Group, an estimated $23.2K added.
- The largest Clearmind Medicine seller in Q2 2024 was Susquehanna International Group, an estimated $27.3K sold.
Based on aggregated 13F filings for Q2 2024.